Investors & Media

Aug 17, 2018 4:38 PM EDT

Copyright Nasdaq. Minimum 15 minutes delayed.

Investors & Media

Investor FAQ

Keryx Biopharmaceuticals was incorporated in Delaware in October 1998
Keryx Biopharmaceuticals common stock is traded on the NASDAQ Capital Market under the ticker symbol "KERX"
July 28, 2000
Cusip #492515101
One Marine Park Drive, 12th Floor, Boston MA 02210
Keryx Biopharmaceuticals does not offer a direct stock purchase plan. Shares of the Company should be purchased through a broker.
Keryx Biopharmaceuticals does not currently pay dividends.
American Stock Transfer & Trust Co.
6201 15th Avenue
Brooklyn, NY 11219
Phone: (800) 937-5449
To replace lost certificates, contact the transfer agent or visit their website: www.amstock.com for a free web tool for shareholders.
To change address, contact the transfer agent or visit their website: www.amstock.com for a free web tool for shareholders.
Keryx Biopharmaceuticals fiscal year is based on the calendar year. First Quarter ends 3/31, Second Quarter ends 6/30, Third Quarter ends 9/30 and Fourth Quarter ends 12/31.
Keryx Biopharmaceuticals is focused on the acquisition, development and commercialization of pharmaceutical products for the treatment of renal disease.

Investor FAQ